“Algorithms for Inference Following Bernoulli Random Walks with Desirable Absorbing Boundaries”, in Society for Clinical Trials Annual Meeting, Boston, MA, 2013.
, “Association Between Center Point Thickness and Visual Acuity in SCORE Study Patients With Macular Edema Due to Retinal Vein Occlusion”, in American Academy of Ophthalmology Annual Meeting, Atlanta, GA, 2008.
, “Clinic vs. Reading Center Evaluation of Dense Retinal Hemorrhage at Baseline in the SCORE Branch Retinal Vein Occlusion (BRVO) Study”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
, “Closed Testing versus Hochberg's Method for Strongly Controlling Family-Wide Type I Error When Making All Pairwise Comparisons of Means in the SCORE Study”, presented at the 04/2008, St. Louis MO, 2008.
, “Estimating Death Rates In Substance Use Disorder”, in The Society for Clinical Trials 33rd Annual Meeting, Miami, FL, 2012.
, “Exact Likelihood Ratio Trend Test Using Correlated Binary Data”, in International Biometric Society Eastern North American Region, Atlanta, GA, 2007.
, “Proc Sql for Exact Testing Trend in Proportions”, in South East SAS Users Group, St. Petersburg Beach, FL, 2008.
, “The Relation Between Depression and Visual Functioning. The AREDS Study”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2005.
, “The SCORE Study: Design and Baseline Characteristics”, in American Academy of Ophthalmology Annual Meeting, Atlanta, GA, 2008.
, “Tangency Outcomes for Clinical Trials”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.
, “Testing versus Hochberg's Method for Strongly Controlling Family-Wide Type I Error When Making All Pairwise Comparisons of Means in the SCORE Study”, in Association for Research in Vision and Ophthalmology Annual Meeting, Fort Lauderdale FL, 2008.
, “Adjusting Moran's I for population density.”, Stat Med, vol. 14, no. 1, pp. 17-26, 1995.
, “Assessment of Immature Platelet Fraction in the Diagnosis of Wiskott-Aldrich Syndrome”, Front Pediatr, vol. 3, 2015.
, “Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10”, Ophthalmology, vol. 118, pp. 345-352, 2011.
, , “Design of NIDA CTN Protocol 0047: Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED)”, Am J Drug Alcohol Abuse, vol. 37, pp. 417-425, 2011.
, “Disease clusters in structured environments.”, Stat Med, vol. 15, no. 7-9, pp. 851-71, 1996.
, , “Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15”, JAMA Ophthalmol, 2015.
, “Influence of Prior Assignment on Refusal Rates in a Trial of Supplemental Oxygen for Retinopathy of Prematurity”, Paediatr Perinat Epidemiol, vol. 20, pp. 348-359, 2006.
, “Motor Function and Human Immunodeficiency Virus-Associated Cognitive Impairment in a Highly Active Antiretroviral Therapy-Era Cohort”, Arch Neurol, vol. 65, pp. 1096-1101, 2008.
, “Power of Automated Algorithms for Combining Time-Line Follow-Back and Urine Drug Screening Test Results in Stimulant-Abuse Clinical Trials”, Am J Drug Alcohol Abuse, vol. 37, pp. 350-357, 2011.
, “A problem with synthetic maps”, Hum Biol, vol. 71, pp. 1-13, 1999.
, “A Pulmonary Score for Assessing the Severity of Neonatal Chronic Lung Disease”, Pediatrics, vol. 115, pp. e450-e457, 2005.
, ,